Minor Determinants of Penicillin and Amoxicillin Are Still Key Components of Penicillin Skin Testing

Dayne Voelker1, Mitchell Pitlick1, Alexei Gonzalez-Estrada2

  • 1Mayo Clinic School of Graduate Medical Education, Mayo Clinic, Rochester, Minn.

Abstract

Insights

The positive rate of penicillin skin testing (PST) has significantly decreased over time. While benzylpenicillin polylysine results remained stable, minor determinants and amoxicillin are increasingly important in positive PST results.

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • The positive rate and patterns of penicillin skin tests (PST) are reportedly decreasing and changing.
  • Previous research shows conflicting results regarding the dominant component in positive PST results.

Purpose of the Study:

  • To analyze historical and current PST patterns.
  • To determine if different determinants in PST have evolved over time.

Main Methods:

  • Retrospective review of electronic medical records from January 2001 to December 2017.
  • Patients undergoing PST were divided into four cohorts based on time periods: 2001-2005, 2006-2010, 2011-2015, and 2016-2017.
  • Analysis of positive PST rates and specific determinant reactivity across cohorts.

Main Results:

  • A total of 30,883 patients underwent PST.
  • The overall positive PST rate (wheal ≥ 3x3 mm) decreased significantly from 1.7% in cohort 1 (2001-2005) to 0.6% in cohorts 3 (2011-2015) and 4 (2016-2017).
  • While benzylpenicillin polylysine positivity remained relatively stable (19-34%), positivity for minor determinants and amoxicillin increased over time, particularly when a 5x5 mm wheal was considered positive.

Conclusions:

  • The overall positive penicillin skin test rate is declining.
  • Minor penicillin determinants and amoxicillin are increasingly significant in positive PST results.
  • Consideration should be given to incorporating these minor determinants and amoxicillin into standard PST protocols.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
406
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
252
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.0K
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
173
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
462
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
884